2017 Biotechnology Law 
Legal Planet
DECEMBER 3, 2024
We had large waitlists from both law and college students. There have been over 80 Rights of Nature (RoN) laws passed across the U.S., In all, there have been over 500 RoN laws, cases, policies and declarations around the globe, and the numbers are increasing. One thing is for sure — there is huge student interest in the topic.
National Law Center
JUNE 4, 2025
The Ag & Food Law Update > Search Site Navigation About the Center Professional Staff Partners Research by Topic Center Publications Webinar Series State Compilations Farm Bill Resources Ag Law Bibliography Ag Law Glossary Ag Law Reporter General Resources 04 Jun NALC news release: National Ag Law Center webinar to examine U.S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
National Law Center
JUNE 12, 2025
The Ag & Food Law Update > Search Site Navigation About the Center Professional Staff Partners Research by Topic Center Publications Webinar Series State Compilations Farm Bill Resources Ag Law Bibliography Ag Law Glossary Ag Law Reporter General Resources 12 Jun The Feed: Vol. 3, Issue 11, from June 12, 2025.
National Law Center
JUNE 10, 2025
However, the court disagreed, concluding that Swampbuster is a valid exercise of Congress’s spending power and that the law should be upheld. Share: Recent Posts Federal Court Finds Swampbuster Constitutional NALC news release: National Ag Law Center webinar to examine U.S. 5 U.S.C. §
Arnold Porter
JUNE 2, 2021
in one of the most closely watched biotechnology cases in recent years. In 2014, another biotechnology company sought billions of dollars in damages and a permanent injunction against the sale of Sanofi and Regeneron's lifesaving and cholesterol-reducing drug Praluent over patent disputes.
Arnold Porter
JUNE 2, 2021
The direct purchasers' suit, filed in 2012, alleged that GSK and Teva violated the antitrust laws through their settlement agreement to end a patent dispute over GSK's anti-epilepsy drug Lamictal and Teva's generic equivalent, lamotrigine.[[N:Complaint, and its subsidiary, AbbVie Biotechnology, Ltd. 3d 184 (3d Cir. Abbvie Inc.
National Law Center
JUNE 17, 2025
3, Issue 11 Federal Court Finds Swampbuster Constitutional NALC news release: National Ag Law Center webinar to examine U.S. Share: Recent Posts FDA Updates: June 2025 The Feed: Vol.
Expert insights. Personalized for you.
279 
Let's personalize your content